Imaging of Mucosal Inflammation: Current Technological Developments, Clinical Implications, and Future Perspectives
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Immunology 8 (2017).
- Keyword
-
-
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2017
- Creator
-
Waldner, Maximilian J.
Rath, Timo
Schürmann, Sebastian
Bojarski, Christian
Atreya, Raja
- URN
-
urn:nbn:de:bvb:29-opus4-94968
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Waldner, Maximilian J.
- Rath, Timo
- Schürmann, Sebastian
- Bojarski, Christian
- Atreya, Raja
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2017
Other Objects (12)
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Update: chronisch entzündliche Darmerkrankungen
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Effektivität und Sicherheit nach einem Switch vom Originator Infliximab auf das Biosimilar SB2 bei CED-Patienten: 24-Monatsdaten einer prospektiven Kohortenstudie
Molekularer Wirkmechanismus eines TLR-9-Agonisten bei Colitis ulcerosa
Endoscopic Therapy in Inflammatory Bowel Diseases
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Role of the IL23/IL17 Pathway in Crohn’s Disease
Multispektrale Optoakustische Tomographie zur ex vivo Untersuchung von Pleuraergussflüssigkeit (MSOT_pleural effusion ex vivo)
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab
Targeting mucosal healing in Crohn’s disease: what the clinician needs to know
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Update: chronisch entzündliche Darmerkrankungen
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Effektivität und Sicherheit nach einem Switch vom Originator Infliximab auf das Biosimilar SB2 bei CED-Patienten: 24-Monatsdaten einer prospektiven Kohortenstudie
Molekularer Wirkmechanismus eines TLR-9-Agonisten bei Colitis ulcerosa
Endoscopic Therapy in Inflammatory Bowel Diseases
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Role of the IL23/IL17 Pathway in Crohn’s Disease
Multispektrale Optoakustische Tomographie zur ex vivo Untersuchung von Pleuraergussflüssigkeit (MSOT_pleural effusion ex vivo)
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab
Targeting mucosal healing in Crohn’s disease: what the clinician needs to know
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Update: chronisch entzündliche Darmerkrankungen
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Effektivität und Sicherheit nach einem Switch vom Originator Infliximab auf das Biosimilar SB2 bei CED-Patienten: 24-Monatsdaten einer prospektiven Kohortenstudie
Molekularer Wirkmechanismus eines TLR-9-Agonisten bei Colitis ulcerosa
Endoscopic Therapy in Inflammatory Bowel Diseases
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Role of the IL23/IL17 Pathway in Crohn’s Disease
Multispektrale Optoakustische Tomographie zur ex vivo Untersuchung von Pleuraergussflüssigkeit (MSOT_pleural effusion ex vivo)
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab